Albright’s recalls one lot of raw chicken dog food over Salmonella: full analysis

CURRENT FULL VERSION: Albright’s Raw Pet Food has issued a voluntary recall of one lot of its Chicken Recipe for Dogs Complete and Balanced after routine FDA sampling found potential Salmonella contamination. The affected product is sold as frozen 1-pound bricks in clear vacuum pouches, typically packed in 30-pound cases, and the recall applies specifically to lot C001730 with a best-by date of April 28, 2027. FDA posted the company’s announcement on May 7, 2026, one day after Albright’s issued it. (fda.gov)

The company said the recalled lot was distributed directly to consumers nationwide, through online sales, and to a small number of retailers in Massachusetts, California, South Carolina, North Carolina, Wisconsin, and New York. According to the FDA notice, the positive finding came from one composite sample collected during routine agency testing for Salmonella, Listeria monocytogenes, and Escherichia coli. No illnesses in pets or humans had been confirmed at the time of the announcement. (fda.gov)

This isn’t the first time Albright’s has faced a Salmonella-related recall. FDA records show the company also recalled chicken dog food in 2020 over possible Salmonella contamination. While the current event is limited to a single lot, the repeat appearance of a pathogen-related recall in a raw product category that already carries well-documented microbial risk will likely keep attention on manufacturing controls, environmental monitoring, and supplier verification. That broader scrutiny has only intensified as outside infectious-disease commentary on other recent raw-pet-food recalls has highlighted how contamination problems can sometimes extend well beyond the first lots identified, especially when sanitation or facility-level controls are inadequate. (fda.gov)

In its recall notice, Albright’s said the pathogen load had not been quantified and that third-party confirmatory testing was still pending, but that it was moving ahead “to ensure the highest level of safety and transparency.” Trade coverage in Pet Food Processing and dvm360 echoed that point and noted the company is continuing its investigation. For pet parents, the company advised against feeding the product and said unused food should be discarded so children, pets, and wildlife can’t access it. (fda.gov)

The broader public health backdrop matters here. CDC says it does not recommend feeding raw pet food because raw meat and other raw animal proteins can contain germs including Salmonella and Listeria. FDA similarly states that raw pet food is more likely than processed pet food to contain harmful bacteria, and notes that exposed pets may show no symptoms while still shedding pathogens in feces and saliva. That asymptomatic shedding risk is especially relevant in households where veterinary teams are advising pet parents about zoonotic exposure. Recent expert commentary on a separate raw-food Listeria recall has also pointed out that Listeria brings an added concern: it can persist in production facilities when cleaning, disinfection, and maintenance are suboptimal, which can increase the chance of prolonged or widespread contamination. (cdc.gov)

That same commentary also underscored two practical issues for clinicians: first, contamination in raw diets may be more common than recall activity alone suggests; and second, illnesses linked to pathogens such as Listeria may be underrecognized in dogs and cats because they are not routinely tested for in everyday practice. While that observation comes from discussion of another company’s recall rather than this Albright’s event specifically, it helps explain why the absence of confirmed cases at the time of a recall should not be read as proof that no animal or human exposures have occurred.

Why it matters: For veterinary professionals, this recall is less about one lot number and more about the recurring clinical and communication challenges tied to raw feeding. Dogs eating contaminated diets may present with nonspecific GI illness, or they may appear clinically normal while creating exposure risk for people and other animals in the home. Practices may want to revisit how consistently they document diet history, flag raw-fed patients in the medical record, and counsel pet parents on food handling, environmental cleaning, and the added risks for children, older adults, and immunocompromised household members. The larger lesson from recent raw-food recall commentary is that once contamination is identified, especially with organisms capable of persisting in facilities, clinicians should stay alert for the possibility that the initially named product may not be the only exposure worth discussing with clients. (fda.gov)

There’s also an operational angle for clinics. Teams handling fecal samples, hospitalized raw-fed patients, or contaminated bowls and carriers may need to think beyond the individual case to infection control workflows. The absence of confirmed illnesses in this recall is reassuring, but it doesn’t eliminate concern, particularly because recalls triggered by routine surveillance can identify risk before clinical cases are recognized. That makes early client outreach and practical guidance more valuable, not less. This is an inference based on the FDA notice and federal public health guidance on raw diets. (fda.gov)

What to watch: The next signal will be whether third-party confirmatory testing supports the initial FDA finding, and whether FDA or the company expands the recall, reports illnesses, or shares more detail on root cause and corrective actions. Recent discussion of other raw-pet-food recalls has also raised a separate policy and trust issue: delays between FDA concern and company action can increase exposure risk. There’s no indication of that kind of delay here, but it remains a useful lens for evaluating future updates. (fda.gov)